Has Lauren Geaney, MD received payments from drug or device companies?

Yes. Drug and device makers reported $262,732 in general payments to Lauren Geaney, MD across 199 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lauren Geaney, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lauren Geaney, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lauren Geaney, MD

Orthopaedic Surgery · Farmington, CTNPI 1285891721

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $164,759 of the $262,732 with a category attached, or 62.7%. 10 manufacturers reported payments, led by Paragon 28, Inc. at 52.3% of the total. 2025 is the largest year on record at $99,309, more than ten times the $1,161 reported in 2019. Among orthopaedic surgery clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$262,732in general payments, 2019–2025

Across 199 payments — averaging $1320.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Paragon 28, Inc.$137K
Smith+Nephew$103K
Novastep Inc.$11K
Vilex LLC$10K
Kairos Surgical Inc$1K
Linvatec Corporation$160
plus $300 from 4 others

$4,637in research payments, 2019–2025

Across 2 payments — averaging $2318.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Paragon 28, Inc.$5K

What the payments were for

Royalty or licence$30,24312%
Consulting fees$164,75963%
Speaking & faculty fees$23,1309%
Travel & lodging$36,23814%
Food & beverage$7,1623%
Education$1,2000%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Paragon 28, Inc.	88	$137,332
Smith+Nephew	71	$102,738
Novastep Inc.	24	$10,735
Vilex LLC	6	$10,244
Kairos Surgical Inc	2	$1,223
Linvatec Corporation	1	$160
Zimmer Biomet	2	$107
Medline Industries LP	2	$71
Bioventus LLC	1	$65
Stryker	2	$56

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Portfolio$99,143
FOOTPRINT$33,923
SALTO TALARIS TOTAL ANKLE PROSTHESIS$33,917
Q-FIX$33,483
Product Portfolio$31,867
Cadence$29,197
Osteoraptor$28,800
Panta 2$22,187
Bone Anchors with Arthroscopic Delivery System$11,805
EVOS$10,632
EVOS MINI$10,530
Integra XT$10,530
N/A$9,617
Healicoil$8,100
CENTROLOCK MIS Bunion Correction$6,750
Biosure$6,075
Bioinductive Implant with Arthroscopic Delivery System - Medium$6,075
DYNEX$5,875
MICRORAPTOR$4,050
NA$2,905

How this compares

$262,732 in reported general payments places this provider in the 95th percentile of 273 orthopaedic surgery providers in Connecticut.

See all orthopaedic surgery providers in Connecticut →

Medicare billing

Part B allowed, 2024

$69,720

Medicare patients

173

Services billed

1,455

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	75	$238
Ibuprofen	34	$120
Ondansetron Hcl	13	$89
Meloxicam	12	$12

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Farmington

James PaceFarmington$721K
Isaac MossFarmington$676K
Cory EdgarFarmington$112K
Antonio CusanoFarmington$25K
Matthew PartanFarmington$24K
Morenikeji BuraimohFarmington$22K
Peter WhangNew Haven$1.8M
Paul SethiGreenwich$1.5M
James YueShelton$1.3M
Robert DeveneyDanbury$907K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →